Myopia in Children: Epidemiology, Genetics, and Emerging Therapies for Treatment and Prevention
2024

Myopia in Children: Causes and Treatments

publication Evidence: high

Author Information

Author(s): Surico Pier Luigi, Parmar Uday Pratap Singh, Singh Rohan Bir, Farsi Yeganeh, Musa Mutali, Maniaci Antonino, Lavalle Salvatore, D’Esposito Fabiana, Gagliano Caterina, Zeppieri Marco

Primary Institution: Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School

Hypothesis

This review aims to connect epidemiological insights with therapeutic applications in pediatrics regarding myopia.

Conclusion

The review highlights the importance of early intervention and emerging therapies to manage and prevent myopia progression in children.

Supporting Evidence

  • Myopia is a significant public health concern with rising prevalence among children.
  • Environmental factors like screen time and lack of outdoor activity contribute to myopia.
  • Genetic predisposition plays a crucial role in the development of myopia.
  • Low-dose atropine is an effective treatment for slowing myopia progression.
  • Public health initiatives can significantly reduce the incidence of myopia.

Takeaway

Myopia is when kids can't see far away, and it's getting more common. Doctors can help by suggesting outdoor play and special treatments.

Methodology

This narrative review was conducted through a comprehensive literature search using PubMed with various keywords related to myopia.

Limitations

The literature search was limited to PubMed and may not include all relevant studies, and the review is subjective.

Digital Object Identifier (DOI)

10.3390/children11121446

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication